International Patent: PHARMACEUTICAL COMPOSITION CONTAINING TLR AGONIST AND MULTIPLE ANTIBODIES, COMBINED FORMULATION, PHARMACEUTICAL USE, AND METHOD OF TREATMENT

GENEVA, July 31 -- PARR BIOTECHNOLOGY (HEBEI) CO., LTD. filed a patent application (CN2025/147419) for “PHARMACEUTICAL COMPOSITION CONTAINING TLR AGONIST AND MULTIPLE ANTIBODIES, COMBINED FORMULATION, PHARMACEUTICAL USE, AND METHOD OF TREATMENT”. With publication no. WO/2026/157845, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 39/395

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....